Pharmaceutical Company Agrees to Pay $360M for Role in Kickback Scheme
Actelion Pharmaceuticals US Inc. has agreed to pay $360 million for allegedly paying kickbacks to medicare patients through a purportedly independent charitable foundation.
by Banker & Tradesman | Dec 7, 2018
Actelion Pharmaceuticals US Inc. has agreed to pay $360 million for allegedly paying kickbacks to medicare patients through a purportedly independent charitable foundation.
We're sorry, it appears you don't have the proper subscription to view this page. Please click the button below to purchase or renew your subscription and gain access to this content.
Questions? Please contact us at 617.896.5367, or send us an email at subscriptions@thewarrengroup.com.
It appears someone has logged in to your account from another device. Please click the button below to log back in on this device, and terminate all other sessions.
Questions? Please contact us at 617.896.5367, or send us an email at subscriptions@thewarrengroup.com.
Already have a subscription?
Need a subscription?
Special offer for new subscribers –
try B&T online for just $9.99 for your first month!
Just looking for the headlines?
If you need assistance with your subscription, please visit our customer service form or email customerservice@thewarrengroup.com.